← Back to Search

Virus Therapy

V-SARS recipients for Coronavirus (COVID-19 Trial)

Phase 1 & 2
Waitlist Available
Led By Aldar Bourinbayar, MD/PhD
Research Sponsored by Immunitor LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 days
Awards & highlights

COVID-19 Trial Summary

Safety and immunogenicity one-month study in healthy individuals administered once-daily pill of therapeutic vaccine made from heat-inactivated plasma from donors with COVID-19. Healthy, at least 20, volunteers will be monitored for signs of adverse events. Their PBMC will be collected at baseline and one month later to analyze which type of immune response vaccine has induced.

Eligible Conditions
  • Coronavirus

COVID-19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effect on CBC as per CTCAE v4.0
Effect on biochemistry parameters as per CTCAE v4.0
Secondary outcome measures
Lack of adverse events as per CTCAE v4.0

COVID-19 Trial Design

1Treatment groups
Experimental Treatment
Group I: V-SARS recipientsExperimental Treatment1 Intervention
Single arm having at least 20 volunteers administered once-per-day pill of V-SARS

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Immunitor LLCLead Sponsor
13 Previous Clinical Trials
902 Total Patients Enrolled
Immunitor Inc.Industry Sponsor
1 Previous Clinical Trials
120 Total Patients Enrolled
Aldar Bourinbayar, MD/PhDPrincipal InvestigatorImmunitor LLC
1 Previous Clinical Trials
20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Tableted COVID-19 Therapeutic Vaccine
2020. "Tableted COVID-19 Therapeutic Vaccine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04380532.
All > Covid
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top